Immuron (IMRN) Interest Coverage Ratio (2016 - 2024)
Immuron (IMRN) posted quarterly Interest Coverage Ratio of 631383620.69 for Q4 2024, down 125243619.8% year-on-year from N/an in Q1 2024, and down 125243619.8% on a QoQ basis from 504.12 in Q4 2023.
Immuron (IMRN) Interest Coverage Ratio (2016 - 2024) Analysis & Trends
Immuron (IMRN) has reported Interest Coverage Ratio for 9 consecutive years, with 631383620.69 the latest figure, recorded in Q4 2024.
- Quarterly Interest Coverage Ratio fell 125243619.8% year-over-year to 631383620.69 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 631382729.78 (down 13926.57% YoY) and the FY2025 annual result came in at 731.63, up 4.45% from the prior year.
- Interest Coverage Ratio declined to 631383620.69 in Q4 2024 per IMRN's latest filing, from 504.12 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for IMRN reached as high as 216725714.29 in Q4 2021 and fell as low as 631383620.69 in Q4 2024.
- A 5-year average of 69109736.04 and a median of 43.16 in 2020 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2021 — Interest Coverage Ratio jumped 10388338562.38% — and 2024, when it slumped 125243619.8%.
- Year by year, Interest Coverage Ratio stood at 2.09 in 2020, then soared by 10388338562.38% to 216725714.29 in 2021, then sank by 100.0% to 84.23 in 2022, then jumped by 498.53% to 504.12 in 2023, then sank by 125243619.8% to 631383620.69 in 2024.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 631383620.69, 504.12, and 1100.27 for Q4 2024, Q4 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -631.38 Mn |
| Dec 31, 2023 | 504.12 |
| Jun 30, 2023 | -1,100.27 |
| Dec 31, 2022 | 84.23 |
| Dec 31, 2021 | 216.73 Mn |
| Dec 31, 2020 | 2.09 |
| Dec 31, 2019 | 741,007.76 |
| Dec 31, 2018 | 40,562.51 |
| Dec 31, 2017 | -979.19 |
| Dec 31, 2016 | 87.93 |
| Jun 30, 2016 | -20.12 |